Regional
Tri County Emergency Medical Services, Inc.
Tri County Emergency Medical Services, Inc. (TX) carries 33 drugs across 129 dose entries in its current published protocol, effective 2023-09-01.
The current listed document is more than 24 months old and may be outdated.
Drugs and doses33
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | pages 15, 150 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | pages 15, 150 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 16 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | pages 16, 137 |
| Asthma / bronchospasm | peds | 0.05 mg/kg | NEB | not captured | standing | page 16 |
| Asthma / bronchospasm | peds | 0.15 mg/kg | NEB | not captured | standing | pages 16, 137 |
| COPD | adult | 2.5 mg | NEB | not captured | standing | page 16 |
| Other | adult | 2.5 mg | NEB | not captured | standing | page 16 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV/IO | not captured | standing | page 17 |
| Other | adult | 300 mg | IV/IO | not captured | standing | pages 17, 80, 138 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | pages 17, 80, 138 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 17 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | pages 18, 72 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5–1 mg | IV/IO | not captured | standing | pages 19, 74, 140 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | pages 19, 74, 140 |
| Organophosphate poisoning | adult | 1–2 mg | IV | not captured | standing | page 19 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV | not captured | standing | page 146 |
| Other | adult | 2 mg | IV | not captured | standing | page 19 |
Clonidine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg | PO | not captured | standing | pages 20, 94 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV | not captured | standing | pages 21, 88 |
| Hypoglycemia | peds | 0.5 g/kg | IV | not captured | standing | pages 21, 88 |
| Other | peds | 1–2 mL/kg | IV/IO | not captured | standing | page 136 |
| Other | peds | 2–4 mL/kg | IV/IO | not captured | standing | page 136 |
| Other | peds | 2–4 mL/kg | IV/IO | not captured | standing | page 136 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | pages 22, 23 |
| Other | adult | 0.25 mg/kg | IV | not captured | standing | pages 22, 23 |
| Other | adult | 0.25 mg/kg | IV | not captured | standing | pages 22, 23 |
| SVT | adult | 0.25 mg/kg | IV | not captured | standing | pages 22, 23 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 25–50 mg | IV/IM | not captured | standing | page 24 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 24 |
| Dystonic reaction | adult | 25–50 mg | IV/IM | not captured | standing | page 24 |
| Dystonic reaction | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 24 |
| Other | adult | 25–50 mg | IV/IM | not captured | standing | page 24 |
| Other | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 24 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 2–5 mcg/kg | IV | not captured | standing | page 25 |
| Cardiogenic shock | peds | 2–5 mcg/kg | IV | not captured | standing | page 25 |
| Hypotension / shock | adult | 2–5 mcg/kg | IV | not captured | standing | page 25 |
| Hypotension / shock | peds | 2–5 mcg/kg | IV | not captured | standing | page 25 |
| Other | adult | 2–5 mcg/kg | IV | not captured | standing | page 25 |
| Other | adult | 2–5 mcg/kg | IV | not captured | standing | page 25 |
| Other | peds | 2–5 mcg/kg | IV | not captured | standing | page 25 |
| Other | peds | 2–5 mcg/kg | IV | not captured | standing | page 25 |
| Sepsis | adult | 2–5 mcg/kg | IV | not captured | standing | page 25 |
| Sepsis | peds | 2–5 mcg/kg | IV | not captured | standing | page 25 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | page 27 |
| Anaphylaxis | adult | 0.5 mg | SQ | not captured | standing | page 27 |
| Anaphylaxis | adult | 0.5 mg | IV | not captured | standing | page 27 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | page 27 |
| Asthma / bronchospasm | adult | 0.5 mg | IV | not captured | standing | page 27 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 27 |
| Cardiac arrest | adult | 0.5–1 mg | SL | not captured | standing | page 27 |
| Cardiac arrest | adult | 0.5–1 mg | IV/IO | not captured | standing | pages 26, 27 |
| Cardiac arrest | adult | 1–2 mg | ET | not captured | standing | page 26 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 26, 27 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV | not captured | standing | page 28 |
| Other | peds | 0.3 mg/kg | IV | not captured | standing | page 28 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 50–100 mcg | IV/IO/IM/IN | not captured | standing | pages 29, 108 |
| Mild to moderate pain | peds | 1–2 mcg/kg | IV/IO/IM/IN | not captured | standing | pages 29, 108 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40 mg | IV | not captured | standing | page 30 |
| CHF / pulmonary edema | peds | 1 mg/kg | IV | not captured | standing | page 30 |
Haloperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 2.5 mg | IV/IM | not captured | standing | page 31 |
| Other | adult | 5 mg | IV/IM | not captured | standing | page 31 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | peds | Follow bottle pre-weight | PO | not captured | standing | pages 9, 143 |
Instant Glucose Paste
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 or 30 grams | PO | not captured | standing | page 32 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | NEB | not captured | standing | page 33 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 34 |
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | page 34 |
| Other | adult | 4 mg/kg | IM | not captured | standing | page 34 |
| Mild to moderate pain | adult | 0.3–0.5 mg/kg | IM | not captured | standing | page 34 |
| Mild to moderate pain | adult | 0.5 mg/kg | IN | not captured | standing | page 34 |
| Procedural sedation | adult | 1 mg/kg | IV/IO | not captured | standing | page 34 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5–10 mg | IV | not captured | standing | page 35 |
| Other | peds | 0.2–0.5 mg/kg | IV | not captured | standing | page 35 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV | not captured | standing | page 38 |
| Other | peds | 1 mg/kg | IV | not captured | standing | page 38 |
| VF / pulseless VT | adult | 1.5 mg/kg | IV/IO | not captured | standing | pages 38, 80 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | pages 38, 80 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 39 |
| Asthma / bronchospasm | adult | 3 g | IV | not captured | standing | page 39 |
| Other | adult | 2 g | IV | not captured | standing | page 39 |
| Other | adult | 2 g | IV | not captured | standing | page 39 |
| Other | adult | 2 g | IV | not captured | standing | page 39 |
| Other | adult | 4–6 g | IV | not captured | standing | page 39 |
| Other | peds | 25–50 mg/kg | IV | not captured | standing | page 39 |
| Seizure | adult | 2 g | IV | not captured | standing | page 39 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IM | not captured | standing | pages 48, 59, 127 |
| Anaphylaxis | peds | 1–2 mg/kg | IV/IM | not captured | standing | pages 48, 59, 127 |
| Asthma / bronchospasm | adult | 125 mg | IV/IM | not captured | standing | pages 48, 69 |
| Asthma / bronchospasm | peds | 1–2 mg/kg | IV/IM | not captured | standing | pages 48, 69 |
| Hypotension / shock | adult | 125 mg | IV/IM | not captured | standing | page 48 |
| Hypotension / shock | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 48 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.1 mg/kg | IV | not captured | standing | page 40 |
| Other | adult | 2 mg | IM | not captured | standing | pages 89, 115 |
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 40 |
| Procedural sedation | adult | 2–2.5 mg | IV/IO/IM/IN | not captured | standing | page 8 |
| Seizure | peds | 0.2–0.3 mg/kg | IN | not captured | standing | pages 40, 118 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2 mg | IV | not captured | standing | pages 41, 85 |
| Mild to moderate pain | adult | 2 mg | IV | not captured | standing | pages 41, 72, 108 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV/IM | not captured | standing | pages 41, 108 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4 mg | IV/IO/IM/IN/ET | not captured | standing | pages 42, 72, 84, 146 |
| Opioid overdose | adult | 1 mg | IN | not captured | standing | page 42 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 43, 72, 94 |
| CHF / pulmonary edema | adult | 0.8 mg | SL | not captured | standing | pages 43, 85 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mcg | IV | not captured | standing | page 37 |
| Other | peds | 0.1 mcg/kg | IV | not captured | standing | page 37 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | IV | not captured | standing | pages 45, 124 |
| Nausea / vomiting | adult | 4–8 mg | ODT | not captured | standing | page 45 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV | not captured | standing | pages 45, 124 |
| Nausea / vomiting | peds | 4 mg | ODT | not captured | standing | page 45 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV | not captured | standing | pages 46, 64, 67, 68 |
| Other | peds | 1 mg/kg | IV | not captured | standing | pages 46, 64, 67, 68 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 1 mEq/kg | IV | not captured | standing | page 47 |
| Asthma / bronchospasm | peds | 2 mEq/kg | IV | not captured | standing | page 47 |
| Hyperkalemia | adult | 1 mEq/kg | IV | not captured | standing | page 47 |
| Hyperkalemia | peds | 2 mEq/kg | IV | not captured | standing | page 47 |
| Hypotension / shock | adult | 1 mEq/kg | IV | not captured | standing | page 47 |
| Hypotension / shock | peds | 2 mEq/kg | IV | not captured | standing | page 47 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 47 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 47 |
| Other | adult | 1 mEq/kg | IV | not captured | standing | page 47 |
| Other | peds | 2 mEq/kg | IV | not captured | standing | page 47 |
| Other | peds | 2 mEq/kg | IV | not captured | standing | page 47 |
| Other | peds | 2 mEq/kg | IV | not captured | standing | page 47 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.25 mg | SQ | not captured | standing | page 49 |
| Asthma / bronchospasm | adult | 0.25 mg | SQ | not captured | standing | pages 49, 69 |
| COPD | adult | 0.25 mg | SQ | not captured | standing | page 49 |
| Other | adult | 0.25 mg | SQ | not captured | standing | pages 49, 69 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | pages 50, 101, 103 |
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 50 |